Onyx Bridge Wealth Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
ATO
CGH
Onyx Bridge Wealth Group's GILD Position: Q2 2026 in Review
Onyx Bridge Wealth Group increased its Gilead Sciences (GILD) stake by 7.5% in Q2 2026, buying an estimated $45.5K and bringing the position to 4,931 shares worth $623K. The position accounts for 0.06% of the portfolio, ranked #210.
Onyx Bridge Wealth Group first reported a position in GILD in Q3 2022 and has held it in 16 quarters since. The position peaked at $639K in Q1 2026. 759 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Onyx Bridge Wealth Group held 4,931 shares of Gilead Sciences worth $623K as of Q2 2026.
- Onyx Bridge Wealth Group bought 345 Gilead Sciences shares in Q2 2026, an estimated $45.5K.
- Gilead Sciences made up 0.06% of Onyx Bridge Wealth Group's portfolio in Q2 2026, its #210 holding.
- Onyx Bridge Wealth Group first reported a position in Gilead Sciences in Q3 2022 and has held it in 16 quarters since.
- Onyx Bridge Wealth Group's Gilead Sciences position peaked at $639K in Q1 2026.
- 759 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Onyx Bridge Wealth Group's 13F filing for Q2 2026, filed 23 Jul 2026.